Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATT vs Steroids for IGRA-Positive Idiopathic Uveitis
NCT05005637Phase 2Completed
- Sponsor
- Faculty of Medicine, Universitas Indonesia
- Start
- Aug 2021
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifampicin, isoniazid, pyrazinamide, ethambutol in tuberculous uveitis (OTB), sponsored by Faculty of Medicine, Universitas Indonesia. Started Aug 2021; status: completed.
02
Drugs
rifampicinisoniazidpyrazinamideethambutol
03
Conditions
tuberculous uveitis (OTB)
Beyond the preview
Go deeper on NCT05005637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05005637.